RXI-231 May Help Fade Hyperpigmentation
RXI-231 may represent a promising approach to the treatment of hyperpigmentation, according to research in Clinical, Cosmetic and Investigational Dermatology. Phio Pharmaceuticals Corp’s RXI-231 is an INTASYL compound designed to target and reduce tyrosinase (TYR) gene expression. INTASYL siRNA gene silencing technology is designed to make the body’s immune cells more effective in killing cancer […]